410 related articles for article (PubMed ID: 12727811)
1. Preinvasive pancreatic neoplasia of ductal phenotype induced by acinar cell targeting of mutant Kras in transgenic mice.
Grippo PJ; Nowlin PS; Demeure MJ; Longnecker DS; Sandgren EP
Cancer Res; 2003 May; 63(9):2016-9. PubMed ID: 12727811
[TBL] [Abstract][Full Text] [Related]
2. The mutant K-ras oncogene causes pancreatic periductal lymphocytic infiltration and gastric mucous neck cell hyperplasia in transgenic mice.
Brembeck FH; Schreiber FS; Deramaudt TB; Craig L; Rhoades B; Swain G; Grippo P; Stoffers DA; Silberg DG; Rustgi AK
Cancer Res; 2003 May; 63(9):2005-9. PubMed ID: 12727809
[TBL] [Abstract][Full Text] [Related]
3. Concomitant pancreatic activation of Kras(G12D) and Tgfa results in cystic papillary neoplasms reminiscent of human IPMN.
Siveke JT; Einwächter H; Sipos B; Lubeseder-Martellato C; Klöppel G; Schmid RM
Cancer Cell; 2007 Sep; 12(3):266-79. PubMed ID: 17785207
[TBL] [Abstract][Full Text] [Related]
4. Origin of pancreatic ductal adenocarcinoma from atypical flat lesions: a comparative study in transgenic mice and human tissues.
Aichler M; Seiler C; Tost M; Siveke J; Mazur PK; Da Silva-Buttkus P; Bartsch DK; Langer P; Chiblak S; Dürr A; Höfler H; Klöppel G; Müller-Decker K; Brielmeier M; Esposito I
J Pathol; 2012 Apr; 226(5):723-34. PubMed ID: 21984419
[TBL] [Abstract][Full Text] [Related]
5. Inactivation of Smad4 accelerates Kras(G12D)-mediated pancreatic neoplasia.
Kojima K; Vickers SM; Adsay NV; Jhala NC; Kim HG; Schoeb TR; Grizzle WE; Klug CA
Cancer Res; 2007 Sep; 67(17):8121-30. PubMed ID: 17804724
[TBL] [Abstract][Full Text] [Related]
6. Early requirement of Rac1 in a mouse model of pancreatic cancer.
Heid I; Lubeseder-Martellato C; Sipos B; Mazur PK; Lesina M; Schmid RM; Siveke JT
Gastroenterology; 2011 Aug; 141(2):719-30, 730.e1-7. PubMed ID: 21684285
[TBL] [Abstract][Full Text] [Related]
7. The c-myc and PyMT oncogenes induce different tumor types in a somatic mouse model for pancreatic cancer.
Lewis BC; Klimstra DS; Varmus HE
Genes Dev; 2003 Dec; 17(24):3127-38. PubMed ID: 14681205
[TBL] [Abstract][Full Text] [Related]
8. Acinar-to-ductal metaplasia accompanies c-myc-induced exocrine pancreatic cancer progression in transgenic rodents.
Grippo PJ; Sandgren EP
Int J Cancer; 2012 Sep; 131(5):1243-8. PubMed ID: 22024988
[TBL] [Abstract][Full Text] [Related]
9. A case of mistaken identity? Nonductal origins of pancreatic "ductal" cancers.
Murtaugh LC; Leach SD
Cancer Cell; 2007 Mar; 11(3):211-3. PubMed ID: 17349578
[TBL] [Abstract][Full Text] [Related]
10. In vitro modeling of human pancreatic duct epithelial cell transformation defines gene expression changes induced by K-ras oncogenic activation in pancreatic carcinogenesis.
Qian J; Niu J; Li M; Chiao PJ; Tsao MS
Cancer Res; 2005 Jun; 65(12):5045-53. PubMed ID: 15958547
[TBL] [Abstract][Full Text] [Related]
11. Acinar cells contribute to the molecular heterogeneity of pancreatic intraepithelial neoplasia.
Zhu L; Shi G; Schmidt CM; Hruban RH; Konieczny SF
Am J Pathol; 2007 Jul; 171(1):263-73. PubMed ID: 17591971
[TBL] [Abstract][Full Text] [Related]
12. Mature acinar cells are refractory to carcinoma development by targeted activation of Ras oncogene in adult rats.
Tanaka H; Fukamachi K; Futakuchi M; Alexander DB; Long N; Tamamushi S; Minami K; Seino S; Ohara H; Joh T; Tsuda H
Cancer Sci; 2010 Feb; 101(2):341-6. PubMed ID: 19917056
[TBL] [Abstract][Full Text] [Related]
13. Where and when does pancreatic carcinoma start?
Lüttges J; Hahn S; Klöppel G
Med Klin (Munich); 2004 Apr; 99(4):191-5. PubMed ID: 15085289
[TBL] [Abstract][Full Text] [Related]
14. Ductal origin of pancreatic adenocarcinomas induced by conditional activation of a human Ha-ras oncogene in rat pancreas.
Ueda S; Fukamachi K; Matsuoka Y; Takasuka N; Takeshita F; Naito A; Iigo M; Alexander DB; Moore MA; Saito I; Ochiya T; Tsuda H
Carcinogenesis; 2006 Dec; 27(12):2497-510. PubMed ID: 16774944
[TBL] [Abstract][Full Text] [Related]
15. Oxidative stress induced by inactivation of TP53INP1 cooperates with KrasG12D to initiate and promote pancreatic carcinogenesis in the murine pancreas.
Al Saati T; Clerc P; Hanoun N; Peuget S; Lulka H; Gigoux V; Capilla F; Béluchon B; Couvelard A; Selves J; Buscail L; Carrier A; Dusetti N; Dufresne M
Am J Pathol; 2013 Jun; 182(6):1996-2004. PubMed ID: 23578383
[TBL] [Abstract][Full Text] [Related]
16. Preinvasive duct-derived neoplasms in pancreas of keratin 5-promoter cyclooxygenase-2 transgenic mice.
Müller-Decker K; Fürstenberger G; Annan N; Kucher D; Pohl-Arnold A; Steinbauer B; Esposito I; Chiblak S; Friess H; Schirmacher P; Berger I
Gastroenterology; 2006 Jun; 130(7):2165-78. PubMed ID: 16762637
[TBL] [Abstract][Full Text] [Related]
17. [Morphologic, morphometric and immunohistochemical studies on pancreatic intraductal hyperplasia and infiltrating carcinoma].
Tomaszewska R
Folia Med Cracov; 1999; 40(1-2):101-41. PubMed ID: 10909469
[TBL] [Abstract][Full Text] [Related]
18. A genetically engineered mouse model developing rapid progressive pancreatic ductal adenocarcinoma.
Yamaguchi T; Ikehara S; Nakanishi H; Ikehara Y
J Pathol; 2014 Oct; 234(2):228-38. PubMed ID: 25042889
[TBL] [Abstract][Full Text] [Related]
19. Ductal pancreatic cancer in humans and mice.
Tuveson DA; Hingorani SR
Cold Spring Harb Symp Quant Biol; 2005; 70():65-72. PubMed ID: 16869739
[TBL] [Abstract][Full Text] [Related]
20. [Differential genetic pathway of duct and acinar carcinomas of the pancreas].
Tsutsumi M
Gan To Kagaku Ryoho; 2005 May; 32(5):593-8. PubMed ID: 15918556
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]